Posts by Muana Minkoué
Three life sciences projects win FONGIT Innovation Fund (FIF) financing
Three innovative projects in the life sciences sectors took home funding from the FONGIT Innovation Fund (FIF) in Geneva: two CHF 100k seed loans for Adjust Medical SA, and Clee Medical; and one CHF 50k grant for Neurovia Bioelectronics. Seed Loan of CHF 100,000 awarded to Adjust Medical SA Primary mitral regurgitation (MR)…
Read MoredEEGtal receives CHF 10’000 from Venture Kick
dEEGtal, who is developing a software for epilepsy diagnosis, has received Venture Kick’s first financial and entrepreneurial support stage with CHF 10’000. The diagnosis of epilepsy is mostly based on visual interpretation of the electroencephalogram (EEG). This method inherently does not provide a diagnosis in 75-80% of the cases, making the diagnosis challenging,…
Read MoreExogems secures CHF 500K in seed-stage financing from business angels
Exogems secures CHF 500’000 in seed-stage financing from business angels to advance therapeutic exosome development. Exogems SA, a pioneering Swiss biotech company developing innovative therapeutic exosomes derived from microfragmented adipose tissue, today announced the successful completion of a CHF 500’000 fundraising round from business angels. This significant investment will fuel the company’s mission…
Read MoreJuliette Lemaignen appointed Director of the Ambulatory Surgery Centre (CCA)
Juliette Lemaignen will take over as director of the Centre for Ambulatory Surgery (CCA) on 1 September 2024. Created jointly by Geneva University Hospitals (HUG) and Hirslanden, it will be operational by the end of 2025. It will be the largest ambulatory surgery centre in Switzerland. Since 2015, Juliette Lemaignen, 45, has been…
Read MoreAn entire brain-machine interface on a chip
Researchers from EPFL have developed a next-generation miniaturized brain-machine interface capable of direct brain-to-text communication on tiny silicon chips. Brain-machine interfaces (BMIs) have emerged as a promising solution for restoring communication and control to individuals with severe motor impairments. Traditionally, these systems have been bulky, power-intensive, and limited in their practical applications. Researchers…
Read MoreATREON awarded first InnoDIGITAL grant
ATREON is the first startup to benefit from PACTT’s new InnoDIGITAL programme, worth CHF 40’000, for the development of an innovative monitoring and management tool for patients suffering from inflammatory arthritis. Earlier this year, ATREON and the PACTT (Technology Transfer Office of the CHUV and UNIL) put in place the licensing terms for…
Read MoreWhat is Series: Swiss Biotech Center
Discover the Swiss Biotech Center, a leading research and development center in the field of biotechnology, in GGBa’s “What is Series”. With its modern facilities and state-of-the-art technologies, Swiss Biotech Center (SBC) is a major player in the promotion of innovation and development of new products and technologies in the field of…
Read MoreSOPHIA DDM™ plateform certified under IVDR
SOPHiA GENETICS, the healthcare technology company and a global leader in data-driven medicine, announced that its SOPHiA DDM™ Platform is now CE marked under the European Union’s In Vitro Diagnostic Regulation (IVDR). IVDR certification is a significant regulatory milestone that validates the powerful analytical capabilities of the SOPHiA DDM™ Platform and allows customers…
Read MoreVandria secures $30.7 Million in Series A funding
Vandria secures $30.7 Million in Series A funding to advance groundbreaking mitophagy therapies. The Vaud-based company announced the second closing of its Series A financing, bringing the final amount raised to date to $30.7 Million (CHF 28.3 Million). Vandria welcomes new institutional investors Hevolution Foundation and Dolby Family Ventures, who have joined its…
Read MoreCSEM announced Andrea Dunbar as new CTO
CSEM announced the appointment of Andrea Dunbar as the new Chief Technology Officer (CTO), effective January 2025. Dunbar will succeed Harry Heinzelmann, who will retire on January 31, 2025, after an esteemed 27-year career with CSEM. Andrea Dunbar joined CSEM in 2007 as a physicist and scientist and has successfully driven innovation, particularly…
Read More